The National Cancer Institute, (NCI) was established by Congress in 1937 as an independent research institute devoted to the discovery of treatments and research of all things related to cancer. Subsequently, the mandate was enlarged and the Institute was provided funds and services through the U.S. National Institutes of Health. NCI has played a significant role in the development of cancer drugs, complex research projects and supported reliable private and quasi-public lab investigations into cancer discoveries. NCI disseminates information freely and welcomes press inquiries, via email, live chat, mail and fax.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
(Phys.org) —In recent years, cancer researchers have been developing agents that destroy the blood vessels surrounding tumors with the goal of starving tumors to death. Some of these agents, such as tumor necrosis factor-alpha ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —Herceptin and camptothecin are both powerful anticancer agents with key characteristics that limit their effectiveness in treating cancer. Patients treated with Herceptin, a monoclonal antibody that targets ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —Activating the body's immune system to attack cancer and prevent it from recurring is one of the Holy Grails of cancer research because of its ability to specifically target cancer and to search almost anywhere ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer ...
Bio & Medicine
May 8, 2013
0
0
(Phys.org)—One of the main reasons that nanoparticles can boost the effectiveness of an anticancer drug while decreasing its toxicity is that they are able to accumulate at cancerous sites in the body through the abnormally ...
Bio & Medicine
Feb 22, 2013
0
0
(Phys.org)—While most nanoparticles under development as drug delivery vehicles are spheres, a growing body of research suggests that cylindrical nanoparticles would perform even better at the twin goal of surviving in ...
Bio & Medicine
Oct 19, 2012
0
0
(Phys.org)—Since the advent of cancer nanotechnology, researchers have sought to use magnetic fields to increase the concentration of drug-loaded iron oxide nanoparticles that reach a tumor. However, magnetic fields drop ...
Bio & Medicine
Oct 19, 2012
0
0
In a nanotechnology two-for-one, researchers at the Johns Hopkins University Center of Cancer Nanotechnology Excellence (Hopkins CCNE) have created a polymer nanoparticle that overcomes tumor resistance to the common anticancer ...
Bio & Medicine
Aug 17, 2012
0
0
One of the challenges in treating cancer, whether using nanotechnology or not, is that tumors can often be inaccessible to the therapies designed to kill them. Mostafa El-Sayed, of the Georgia Institute of Technology, and ...
Bio & Medicine
Aug 17, 2012
3
0
Over the past six years, the National Cancer Institute’s (NCI) Nanotechnology Characterization Laboratory (NCL), a key component of the NCI’s Alliance for Nanotechnology in Cancer, has characterized more than 250 ...
Bio & Medicine
Aug 17, 2012
0
0
